Human FGF9 ELISA Kit (A566)

Human FGF9 ELISA Kit

Sandwich (quantitative)

This FGF9 enzyme linked immunosorbent assay (ELISA) applies a technique called a quantitative sandwich immunoassay. The microtiter plate has been pre-coated with an Anti-FGF9 Antibody. Standards or samples are then added to the microtire plate wells and FGF9, if present, will bind to the antibody pre-coated on the wells. In order to quantify the amount of FGF9 present in the sample, Anti-FGF9 Antibody (Biotin) is added to each well to "sandwich" the FGF9 immobilised on the plate. The microtiter plate then undergoes incubation, followed by thorough washing of the wells to remove all unbound components. Next, Avidin-Biotin-Peroxidase Complex is added to each well for a short incubation period, followed by thorough washing of the wells to remove all unbound conjugates. Next, a TMB (3,3',5,5' tetramethyl-benzidine) substrate solution is added to each well. The enzyme (HRP) and substrate are allowed to react over a short incubation period. Only those wells that contain FGF9 will exhibit a change in colour. The enzyme-substrate reaction is terminated by the addition of a stop solution and the colour change is measured spectrophotometrically at a wavelength of 450nm ± 2nm.

Microplate

Serum, plasma, body fluids, tissue lysates, and cell culture supernatants.

< 15 pg/ml

62.5-4000 pg/ml

Human

Store at 2-8°C for 4 months or at -20°C for 8 months.

FGF 9, FGF-9, FGF9_HUMAN, Fibroblast growth factor 9, GAF, GAF (Glia-activafibroblast growth factor 9 (glia-activating factor), Glia Activating Factor, Glia-activating factor, HBFG 9, HBFG9, HBGF-9, Heparin-binding growth factor 9, MGC119914, MGC119915, SYNS3